In peripheral artery disease (PAD), this randomized trial assessed whether nicotinamide riboside (NR), with and without resveratrol, improved walking, compared to placebo. Here, the authors show that NR meaningfully improves 6-min walk, and resveratrol did not add benefit to NR alone.
- Mary M. McDermott
- Christopher R. Martens
- Christiaan Leeuwenburgh
